From: Feasibility of externalized peritoneovenous shunt (EPVS) for malignant ascites
 | Preoperative Period | 3-POD | 7-POD | 14-POD |
---|---|---|---|---|
Cr, mg/dL | 1.1 (0.6) | 1.2 (0.7) | 1.1 (0.8) | 1.1 (0.9) |
BUN, mg/dL | 21.2 (10.6) | 22.6 (13.7) | 23.5 (13.7) | 27.8 (15.8) |
Albumin, g/dL | 2.3 (0.3) | 2.4 (0.4) | 2.6 (0.5) | 2.5 (0.6) |
PT, % | 70.1 (13.8) | 60.8 (12.5) | 68.6 (13.10) | 67.6 (10.4) |
Platelets, 103 cells/mm3 | 35.8 (9.1) | 26.7 (10.6) | 25.3 (8.7) | 29.3 (6.8) |
Largest abdominal girth, cm | 87.5 (9.6) | 84.1 (10.6) | 81.7 (5.1) | 80.2 (4.8) |
Diuresis, 24 h, mL | 978 (466) | 1723 (560) | 1612 (416) | 1334 (506) |